Christoph Paul Klapproth

Predicting EQ-5D-5L crosswalk from the PROMIS-29 profile for the United Kingdom, France, and Germany

Christoph Paul Klapproth, Jan van Bebber, Christopher J. Sidey-Gibbons et al. · Health and Quality of Life Outcomes · 2020 · 19 citations · Full text

Pharmacy, Health Sciences, Health Economics +16

Comparison of the PROMIS Preference Score (PROPr) and EQ-5D-5L Index Value in General Population Samples in the United Kingdom, France, and Germany

Christoph Paul Klapproth, Christopher J. Sidey-Gibbons, José M Valderas et al. · Value in Health · 2021 · 19 citations · Full text

Pharmacy, Biostatistics, Outcomes Research +12

Scale agreement, ceiling and floor effects, construct validity, and relative efficiency of the PROPr and EQ-5D-3L in low back pain patients

Christoph Paul Klapproth, Felix Fischer, Matthias Rose · Health and Quality of Life Outcomes · 2023 · 17 citations · Full text

Medicine, Orthopedic Surgery, Rehabilitation Medicine +17

Psychometric properties of the PROMIS Preference score (PROPr) in patients with rheumatological and psychosomatic conditions

Christoph Paul Klapproth, Felix Fischer, M. Merbach et al. · BMC Rheumatology · 2022 · 13 citations · Full text

Pharmacy, Psychology, Health Assessment +16

Health state utility differed systematically in breast cancer patients between the EORTC QLU-C10D and the PROMIS Preference Score

Christoph Paul Klapproth, Felix Fischer, Matthias Rose et al. · Journal of Clinical Epidemiology · 2022 · 13 citations

Pharmacy, Oncology, Health Assessment +15